share_log

CVS Health | 8-K: Current report

CVS Health | 8-K: Current report

西维斯健康 | 8-K：重大事件
美股sec公告 ·  05/09 16:27
Moomoo AI 已提取核心信息
On May 9, 2024, CVS Health Corporation successfully issued and sold a series of Senior Notes totaling $5 billion. The offering included 5.400% Senior Notes due 2029, 5.550% Senior Notes due 2031, 5.700% Senior Notes due 2034, 6.000% Senior Notes due 2044, and 6.050% Senior Notes due 2054. This debt issuance was made under the company's Registration Statement on Form S-3ASR, initially filed on May 25, 2023. The Senior Notes are part of a broader agreement governed by a Senior Indenture dated August 15, 2006, between CVS Health and The Bank of New York Mellon Trust Company, N.A., as trustee. The company retains the option to issue additional senior debt securities under this agreement. The forms of the newly issued Notes have been filed with the SEC and are incorporated by reference into the Registration Statement.
On May 9, 2024, CVS Health Corporation successfully issued and sold a series of Senior Notes totaling $5 billion. The offering included 5.400% Senior Notes due 2029, 5.550% Senior Notes due 2031, 5.700% Senior Notes due 2034, 6.000% Senior Notes due 2044, and 6.050% Senior Notes due 2054. This debt issuance was made under the company's Registration Statement on Form S-3ASR, initially filed on May 25, 2023. The Senior Notes are part of a broader agreement governed by a Senior Indenture dated August 15, 2006, between CVS Health and The Bank of New York Mellon Trust Company, N.A., as trustee. The company retains the option to issue additional senior debt securities under this agreement. The forms of the newly issued Notes have been filed with the SEC and are incorporated by reference into the Registration Statement.
2024年5月9日，CVS Health Corporation成功发行并出售了一系列总额为50亿美元的优先票据。此次发行包括2029年到期的5.400％的优先票据、2031年到期的5.550％的优先票据、2034年到期的5.700％的优先票据、2044年到期的6.000％的优先票据和2054年到期的6.050％的优先票据。本次债务发行是根据该公司最初于 2023 年 5 月 25 日提交的 S-3ASR 表格注册声明进行的。优先票据是CVS Health与作为受托人的纽约银行梅隆信托公司于2006年8月15日签订的优先契约管理的更广泛协议的一部分。根据本协议，公司保留发行额外优先债务证券的选择权。新发行的票据的表格已向美国证券交易委员会提交，并以引用方式纳入注册声明。
2024年5月9日，CVS Health Corporation成功发行并出售了一系列总额为50亿美元的优先票据。此次发行包括2029年到期的5.400％的优先票据、2031年到期的5.550％的优先票据、2034年到期的5.700％的优先票据、2044年到期的6.000％的优先票据和2054年到期的6.050％的优先票据。本次债务发行是根据该公司最初于 2023 年 5 月 25 日提交的 S-3ASR 表格注册声明进行的。优先票据是CVS Health与作为受托人的纽约银行梅隆信托公司于2006年8月15日签订的优先契约管理的更广泛协议的一部分。根据本协议，公司保留发行额外优先债务证券的选择权。新发行的票据的表格已向美国证券交易委员会提交，并以引用方式纳入注册声明。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

独立文件7  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息